Fortress Biotech, Inc. (FBIOP) Asset Utilization Ratio (2015 - 2026)
Fortress Biotech (FBIOP) posted quarterly Asset Utilization Ratio of 0.33 for Q4 2025, down 23.35% year-over-year from 0.43 in Q4 2024, and down 8.68% quarter-over-quarter from 0.36 in Q3 2025.
Fortress Biotech, Inc. (FBIOP) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Fortress Biotech's Asset Utilization Ratio history runs 11 years deep, the most recent figure standing at 0.33 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio fell 23.35% year-over-year to 0.33; the TTM figure through Dec 2025 stood at 0.33 (down 23.35% YoY), while the FY2025 annual figure was 0.37, changed 0.38% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 0.33, down from 0.36 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.43 in Q4 2024, with the low at 0.27 in Q3 2023.
- The 5-year median for Asset Utilization Ratio is 0.2 (2022), against an average of 0.17.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio tumbled 220.06% in 2023, then jumped 280.27% in 2024.
- Fortress Biotech's Asset Utilization Ratio stood at 0.2 in 2021, then slumped by 163.04% to 0.12 in 2022, then jumped by 241.0% to 0.17 in 2023, then jumped by 143.51% to 0.43 in 2024, then declined by 23.35% to 0.33 in 2025.
- Business Quant data shows FBIOP's Asset Utilization Ratio at 0.33 in Q4 2025, 0.36 in Q3 2025, and 0.34 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.27 |
| Dec 31, 2025 | 0.33 |
| Sep 30, 2025 | 0.36 |
| Jun 30, 2025 | 0.34 |
| Mar 31, 2025 | 0.36 |
| Dec 31, 2024 | 0.43 |
| Sep 30, 2024 | 0.42 |
| Jun 30, 2024 | 0.28 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | -0.27 |
| Jun 30, 2023 | -0.20 |
| Mar 31, 2023 | -0.10 |
| Dec 31, 2022 | -0.12 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.25 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.20 |
| Sep 30, 2021 | 0.17 |
| Jun 30, 2021 | 0.12 |